BioMaP: RPP Production of Drug Substances and Drug Products at Commercial Scale – Anti-Microbials and Large Volume Parenterals
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The BioMaP solicitation, numbered 24912, focuses on the production of drug substances and drug products at a commercial scale, specifically targeting anti-microbials and large volume parenterals. This opportunity is designed to enhance the manufacturing capabilities for critical pharmaceutical products. The solicitation was posted on November 17, 2026, with a response deadline set for December 3, 2026. There is no specific set-aside status designated for this contract. Interested parties can find further details through the provided ATI link.
General Info
Agency
Place of Performance
Set-Aside
Documents
0No documents available
Documents will appear here when they are available.
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Solicitation
Submission deadline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Get AI-powered intelligence on this solicitation and the ones like it
Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.
Join 900+ contractors already using CLEATUS
